Skip to main content
Clinical Trials/NL-OMON49201
NL-OMON49201
Completed
Not Applicable

A first-in-human, randomized, subject-blinded, placebocontrolled, single ascending dose study to investigate the safety, tolerability and pharmacokinetics of MHS552 in healthy volunteers - A FIH study to investigate the safety, tolerability and PK of MHS552

ovartis0 sites64 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ovartis
Enrollment
64
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial ended prematurely

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ovartis

Eligibility Criteria

Inclusion Criteria

  • Healthy female and male subjects 18 to 45 years of age included, and in good
  • health as determined by past medical history, physical examination, vital
  • signs, electrocardiogram, and laboratory tests at screening and/or baseline.

Exclusion Criteria

  • \- Women of child\-bearing potential, defined as all women physiologically
  • capable of becoming pregnant
  • \- A history of ongoing, chronic or recurrent infectious disease, or evidence of
  • tuberculosis infection
  • \- Receipt of live/attenuated vaccine within a 3\-month period before first dose
  • \- Active, known, or suspected autoimmune disease or documented history of
  • autoimmune disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomized, double-blind, placebo-controlled, three-period two treatment incomplete-block crossover study to investigate the effects of intravenous GSK3858279 on a battery of evoked pain tests in healthy participants.Chronic pain diseases.Chronic pain diseases
NL-OMON55004GlaxoSmithKline30
Completed
Phase 2
A randomized, placebo-controlled, double-blind, parallel-group, multi-center, exploratory dose-response study to assess the efficacy and safety of different oral doses of BAY1128688 in women with symptomatic endometriosis over a 12-week treatment periodpain during intercourse ('dyspareunia') and non-cyclic pelvic pain.Well-accepted lay language synomyms for endometriosis are not known to us. Endometriosis describes the presence of endometrium elsewhere than in the lining of the uterus. It is associated with pelvic pain during menstruation called 'dysmenorrhea'10038612
NL-OMON46660Bayer5
Completed
Phase 3
A randomized, double-blind, placebo-controlled intervention study to assess the therapeutic effect of an extensively hydrolyzed infant formula with an added synbiotic mixture in infants with atopic dermatitis.atopic dermatitiseczema1003871610040785
NL-OMON39465Danone Research - Centre for Specialised Nutrition144
Completed
Phase 2
Double-blind, randomized, placebo-controlled, phase II dose-finding study comparing different doses of Rhudex granules with placebo in the treatment of primary biliary cholangitis
NL-OMON55327AML Clinical Services BV8
Completed
Phase 3
Randomised, double-blind, placebo-controlled, multi-centre trial on the efficacy and safety of budesonide for induction of remission in incomplete microscopic colitisIncomplete microscopic colitisinflammation large intestine10017969
NL-OMON45182Dr. Falk Pharma GmbH1